Ottavio de Cobelli - JoVE Visualize

Showing results (381-390 of 427) with videos related to

Pageof 43

Sort By:

Urologia Internationalis|July 6, 2018

High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional StudyMatteo Ferro, Mihai Dorin Vartolomei, Francesco Cantiello, et al.

Journal of Clinical Medicine|April 12, 2022

Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium)Fabrizio Di Maida, Riccardo Campi, Brian R Lane, et al.

European Urology|July 4, 2012

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project)Sabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.

Clinical Genitourinary Cancer|August 6, 2018

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder CancerMihai Dorin Vartolomei, Matteo Ferro, Francesco Cantiello, et al.

World Journal of Urology|March 1, 2016

Impact of novel techniques on minimally invasive adrenal surgery: trends and outcomes from a contemporary international large series in urologyNicola Pavan, Riccardo Autorino, Hak Lee, et al.

BMC Cancer|January 12, 2021

Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancerAngelo Porreca, Katie Palmer, Walter Artibani, et al.

Medicine|October 27, 2015

Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter ExperienceMatteo Ferro, Ottavio De Cobelli, Carlo Buonerba, et al.

Translational Andrology and Urology|March 15, 2021

Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancerMatteo Ferro, Marina Di Mauro, Sebastiano Cimino, et al.

Urologic Oncology|March 17, 2020

Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.

European Urology Oncology|June 4, 2019

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerFrancesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.

Pageof 43

Showing results (381-390 of 427) with videos related to

Sort By:

Pageof 43

Urologia Internationalis|July 6, 2018

High-Grade T1 on Re-Transurethral Resection after Initial High-Grade T1 Confers Worse Oncological Outcomes: Results of a Multi-Institutional StudyMatteo Ferro, Mihai Dorin Vartolomei, Francesco Cantiello, et al.

Journal of Clinical Medicine|April 12, 2022

Predictors of Positive Surgical Margins after Robot-Assisted Partial Nephrectomy for Localized Renal Tumors: Insights from a Large Multicenter International Prospective Observational Project (The Surface-Intermediate-Base Margin Score Consortium)Fabrizio Di Maida, Riccardo Campi, Brian R Lane, et al.

European Urology|July 4, 2012

Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project)Sabine Brookman-May, Matthias May, Shahrokh F Shariat, et al.

Clinical Genitourinary Cancer|August 6, 2018

Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non-muscle-invasive Bladder CancerMihai Dorin Vartolomei, Matteo Ferro, Francesco Cantiello, et al.

World Journal of Urology|March 1, 2016

Impact of novel techniques on minimally invasive adrenal surgery: trends and outcomes from a contemporary international large series in urologyNicola Pavan, Riccardo Autorino, Hak Lee, et al.

BMC Cancer|January 12, 2021

Protocol of the Italian Radical Cystectomy Registry (RIC): a non-randomized, 24-month, multicenter study comparing robotic-assisted, laparoscopic, and open surgery for radical cystectomy in bladder cancerAngelo Porreca, Katie Palmer, Walter Artibani, et al.

Medicine|October 27, 2015

Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter ExperienceMatteo Ferro, Ottavio De Cobelli, Carlo Buonerba, et al.

Translational Andrology and Urology|March 15, 2021

Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancerMatteo Ferro, Marina Di Mauro, Sebastiano Cimino, et al.

Urologic Oncology|March 17, 2020

Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumorMatteo Ferro, Martha Orsolya Katalin, Carlo Buonerba, et al.

European Urology Oncology|June 4, 2019

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder CancerFrancesco Cantiello, Giorgio I Russo, Mihai Dorin Vartolomei, et al.

Pageof 43